- Telaprevir2012 | Faculty of Medicine in Pilsen
- Adverse effects of telaprevir treatment and their management2013 | Faculty of Medicine in Pilsen
- Sustained virological response with telaprevir in 1078 patients with advanced hepatitis C: The international telaprevir access program2014 | First Faculty of Medicine
- Pharmacokinetics of bound and unbound telaprevir in cirrhotic patients with moderate and severe hepatic impairment2015 | Third Faculty of Medicine
- Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C2014 | First Faculty of Medicine
- Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis2015 | First Faculty of Medicine
- Report of University Hospital Hradec Králové to the clinical trial protocol No. AI452-020-0030Publication without faculty affiliation
- Viral hepatitis at the beginning of the 21th century - State of the Art2011 | First Faculty of Medicine
- USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study2015 | First Faculty of Medicine, Central Library of Charles University